The medical industry introduces new technologies at an increasingly rapid rate. One such technology that has gained popularity over the last five years is the Microstructure Transdermal Systems (MTS) micro needle platform. Using an MTS device for drug delivery is becoming a primary technology due to the growth in biopharmaceuticals over classic small molecules. Biopharmaceuticals feature a variety of new challenges, especially identifying the ideal delivery method. The delivery method must meet both the bioavailability and efficiency requirements of the therapy while simultaneously offering a solution to patients which is noninvasive, comfortable, and convenient.
Using an MTS device for drug delivery offers the best characteristics of both syringe and transdermal patches without the drawbacks. While syringe-based injection systems are valued in the medical community for speed and efficiency, they generally do not score well on patient satisfaction surveys. On the other hand, transdermal drug delivery systems typically receive high patient satisfaction ratings; however the effectiveness of delivery is poor when using biopharmaceuticals.
From a medical standpoint, using an MTS device for drug delivery offers excellent efficacy for both biopharmaceuticals and classic small molecules. The best devices utilize a micro needle unit with a screw thread. This allows for direct drug delivery into the dermis. And MTS device has also proven effective for the transdermal delivery of vaccines, proteins, and antibodies. Along with a high level of effectiveness, this easy-to-use platform provides a significant potential for increased acceptance of new therapies.
From a patient’s standpoint, using an MTS device for drug delivery offers several important benefits. The most important being a minimal pain free delivery option. The less painful a delivery system is, the more likely a patient will comply with the usage directions of a prescribed medicine. Another benefit is MTS devices are extremely easy-to-use which increases the opportunity for patients to self-administer drugs.
By meeting the most important needs of medical practitioners and patients alike make an MTS device for drug delivery and ideal solution. It overcomes the most common patient complaints while offering a high level of drug efficacy. In the long run, this will help decrease the time needed by medical professionals to administer drugs because patients are more willing and able to do so themselves. Additionally, since the MTS device for drug delivery already utilizes a micro needle platform which can support biopharmaceuticals this technology is already capable of meeting the medical communities growing reliance on smaller drug molecules. This ensures the MTS technology can be leveraged far into the foreseea.